Bradley Davis, MD
Urology · Overland Park, KSNPI 1811989585
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.2%), travel and lodging and education — rather than concentrated in one kind of arrangement. Teleflex LLC accounts for 60.8% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2022 at $1,132 and has fallen 54.0% since, to $521 in 2025. That places this record below the midpoint for urology clinicians in KS, where the typical reported total is $2,717.
Across 52 payments — averaging $61.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$2K
- Procept Biorobotics Corporation$312
- Boston Scientific$134
- AbbVie$100
- Agiliti Surgical, Inc.$79
- C. R. Bard, Inc. & Subsidiaries$72
- plus $560 from 16 others
What the payments were for
- Travel & lodging$1,39643%
- Food & beverage$1,80456%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 9 | $1,954 |
| Procept Biorobotics Corporation | 2 | $312 |
| Boston Scientific | 1 | $134 |
| AbbVie(2 entities) | 6 | $100 |
| Agiliti Surgical, Inc. | 1 | $79 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $72 |
| Olympus America Inc. | 4 | $67 |
| Astellas Pharma US Inc | 2 | $57 |
| Coloplast | 4 | $55 |
| Dendreon Pharmaceuticals LLC | 2 | $50 |
| Johnson & Johnson | 3 | $50 |
| Ambu Inc. | 2 | $48 |
| Pfizer | 3 | $47 |
| Rochester Medical Corporation | 2 | $30 |
| 180 Medical, Inc. | 1 | $28 |
| Profound Medical Corp. | 1 | $22 |
| Blue Earth Diagnostics | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Tolmar Pharmaceuticals, Inc. | 1 | $20 |
| Neotract Inc. | 1 | $16 |
| Tolmar, Inc. | 1 | $15 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift$1,678
- AquaBeam Robotic System$312
- Barrigel$139
- GENERAL ERECTILE DYSFUNCTION$134
- UroLift System$104
How this compares
$3,212 in reported general payments places this provider in the 50th percentile of 111 urology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 48 | $43,279 |
| Tamsulosin Hcl | 436 | $6,973 |
| Finasteride | 271 | $3,438 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 99 | $2,295 |
| Solifenacin Succinate | 43 | $1,714 |
| Silodosin | 17 | $1,214 |
| Oxybutynin Chloride | 65 | $1,026 |
| Trospium Chloride | 14 | $674 |
| Dutasteride | 28 | $634 |
| Oxybutynin Chloride ErOxybutynin Chloride | 24 | $608 |
| Doxazosin Mesylate | 28 | $415 |
| Doxycycline Hyclate | 25 | $370 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 26 | $334 |
| Ciprofloxacin Hcl | 73 | $290 |
| Terazosin Hcl | 43 | $115 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $57 | $43,27948 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 111 urology providers in Kansas.
Other urology in Overland Park
- Jason AnastOverland Park$31K
- Christian HettingerOverland Park$14K
- Nathaniel BallekOverland Park$11K
- Mirian BociOverland Park$7K
- Andrew FlumOverland Park$6K
- David BockOverland Park$6K
- Andrew MorrisOverland Park$6K
- Lindsay HertzigOverland Park$3K
- Timothy RichardsonWichita$493K
- Wilson MolinaKansas City$239K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.